Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Jan M, Griffin"'
Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
Autor:
Richard K. Cheng, Alexi Vasbinder, Wayne C. Levy, Parag Goyal, Jan M. Griffin, Douglas J. Leedy, Mathew S. Maurer
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 24 (2021)
Background Despite the belief that heart failure therapies are not effective in transthyretin cardiac amyloidosis, data are limited. We tested the association of neurohormonal blockade use with survival. Methods and Results A total of 309 consecutive
Externí odkaz:
https://doaj.org/article/f510bac7b5b54849850782a81609f5b4
Autor:
Sneha S. Jain, Kevin J. Clerkin, D. Edmund Anstey, Qi Liu, Justin A. Fried, Jayant Raikhelkar, Jan M. Griffin, Dylan Marshall, Paolo Colombo, Melana Yuzefpolskaya, Veli Topkara, Yoshifumi Naka, Koji Takeda, Gabriel Sayer, Nir Uriel, Jay Leb
Publikováno v:
The Annals of Thoracic Surgery. 115:1282-1288
In patients with the HeartMate 3 (HM3, Abbott) left ventricular (LV) assist device (LVAD), outflow graft narrowing has been reported as a result of accumulation of biodebris either internal or external to the graft. This study describes the prevalenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1858035ee5740a80d38136de09b1b4e
https://doi.org/10.1016/j.athoracsur.2021.12.014
https://doi.org/10.1016/j.athoracsur.2021.12.014
Autor:
Jan M. Griffin, Barry A. Borlaug, Jan Komtebedde, Sheldon E. Litwin, Sanjiv J. Shah, David M. Kaye, Elke Hoendermis, Gerd Hasenfuß, Finn Gustafsson, Emil Wolsk, Nir Uriel, Daniel Burkhoff
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 17 (2020)
Approximately 50% of patients with heart failure have preserved ejection fraction. Although a wide variety of conditions cause or contribute to heart failure with preserved ejection fraction, elevated left ventricular filling pressures, particularly
Externí odkaz:
https://doaj.org/article/27a811bf797249db91be68ea1278dbc6
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-3 (2019)
Abstract Background Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been used increasingly to support patients with cardiogenic shock (CS). There has been growing recognition of the favorable and unfavorable hemodynamic effects of thi
Externí odkaz:
https://doaj.org/article/7d688afee4984f8bbc2e58d3b3d6b719
Autor:
Esther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, Giulia Saturi, Mélanie Bezard, Sunil E. Saith, Omar F. AbouEzzeddine, Roberta Mussinelli, Christian Gagliardi, Mounira Kharoubi, Jan M. Griffin, Angela Dispenzieri, Silvia Vilches, Stefano Perlini, Simone Longhi, Silvia Oghina, Adrian Rivas, Martha Grogan, Mathew S. Maurer, Thibaud Damy, Giovanni Palladini, Claudio Rapezzi, Pablo Garcia-Pavia
Publikováno v:
JACC: CardioOncology. 4:442-454
Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognized as a treatable cause of heart failure (HF). Advances in diagnosis and therapy have increased the number of patients diagnosed at early stages, but prognostic data on patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c89295f49394d4776db5184e6706ee8e
https://doi.org/10.1016/j.jaccao.2022.07.007
https://doi.org/10.1016/j.jaccao.2022.07.007
Autor:
Alison L. Wand, Noelle Pavlovic, Chloe Duvall, Natalie S. Rosen, Jessica Chasler, Jan M. Griffin, David R. Okada, Artrish Jefferson, Jonathan Chrispin, Harikrishna Tandri, Stephen C. Mathai, Michelle Sharp, Edward S. Chen, Edward K. Kasper, Allison G. Hays, Nisha A. Gilotra
Publikováno v:
The American Journal of Cardiology. 177:108-115
Cardiac sarcoidosis (CS) is an important cause of cardiomyopathy. The trajectory of left ventricular ejection fraction (LVEF) in patients with CS undergoing treatment remains unclear. Patients with CS who were treated with corticosteroids and who und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec12c2b3586d6941c4b797706ca94e5f
https://doi.org/10.1016/j.amjcard.2022.04.051
https://doi.org/10.1016/j.amjcard.2022.04.051
Autor:
Jaya Batra, Hannah Rosenblum, Francesco Cappelli, Mattia Zampieri, Iacopo Olivotto, Jan M. Griffin, Sunil E. Saith, Sergio Teruya, Jeffeny De Los Santos, Alessia Argiro, Daniel Burkhoff, Federico Perfetto, Mathew S. Maurer
Publikováno v:
Journal of Cardiac Failure. 28:950-959
The valine-to-isoleucine substitution (Val122Ile) is the most common variant of transthyretin (TTR) amyloidosis in the United States, affecting primarily individuals of African descent. This variant has been identified recently in a cluster of white
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b512aecc4e36a39e4ae3f731f8a5bb14
https://doi.org/10.1016/j.cardfail.2021.12.016
https://doi.org/10.1016/j.cardfail.2021.12.016
Autor:
CHLOE DUVALL, NOELLE PAVLOVIC, NATALIE S. ROSEN, ALISON L. WAND, JAN M. GRIFFIN, DAVID R. OKADA, HARIKRISHNA TANDRI, EDWARD K. KASPER, MICHELLE SHARP, EDWARD S. CHEN, JONATHAN CHRISPIN, NISHA A. GILOTRA
Publikováno v:
Journal of Cardiac Failure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::340f3344d23d5a0b8674584115ed299e
https://doi.org/10.1016/j.cardfail.2023.03.022
https://doi.org/10.1016/j.cardfail.2023.03.022
Autor:
Madeleine B. Hopson, Divaya Bhutani, Shawn Sarkaria, Mathew S. Maurer, Jan M. Griffin, Markus Mapara, Suzanne Lentzsch, Rajshekhar Chakraborty
Publikováno v:
Leukemia & Lymphoma. 63:2109-2113
We performed a retrospective cohort study in AL amyloidosis to investigate the impact of light chain (LC) isotype on clinical features in 112 consecutive patients. Patients with kappa LC isotype had a significantly higher difference in free light cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee51ae41e83706c5f0ab36a5453fc19
https://doi.org/10.1080/10428194.2022.2060502
https://doi.org/10.1080/10428194.2022.2060502
Autor:
Eleonore Baughan, Koji Takeda, Maryjane Farr, Jayant Raikhelkar, Justin Fried, Hannah Rosenblum, Thomas H. Brannagan, Mathew S. Maurer, Nir Uriel, Charles C. Marboe, Kevin J. Clerkin, Justin L. Grodin, Jan M. Griffin
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:199-207
Introduction Heart Transplantation (HT) is a rational therapy for advanced transthyretin cardiac amyloidosis (ATTR-CA), but the impact of ongoing amyloid deposition is not well defined. We evaluated a cohort of patients who underwent HT for ATTR-CA t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a60391121682e2af5fa0a9786701081
https://doi.org/10.1016/j.healun.2021.10.007
https://doi.org/10.1016/j.healun.2021.10.007